How can you best manage difficult-to-treat rheumatoid arthritis?
Join our expert-led webinar to explore treatment and management strategies, including the need for a personalized, multidisciplinary approach.
显示更多
How can you best approach difficult-to-treat rheumatoid arthritis?
Join our expert-led webinar to explore treatment and management strategies, including the need for a personalised, multidisciplinary approach.
显示更多
What were the late breaking highlights from EAN 2026?
In an exclusive interview, Dr. Miguel Miranda discusses his takeaways on the ROSSINI trial findings, the latest results for anti-PACAP treatments for migraine, and the potential of GDF-15 for predicting cognitive decline.
显示更多
What were the highlights from the recent EAN congress?
Keep up to date with all the top stories and latest evidence with our hub page, including exclusive expert interviews.
What were the highlights from EAN 2026? Our congress hub page will keep you up to date with all the top stories and latest evidence in neurology research.
Springer Medicine is your trusted partner for coverage of EAN 2026!
We'll bring you breaking news and exclusive interviews direct from the congress.
Bladder cancer management is undergoing one of its most significant periods of change in decades. Is your clinical practice up to date?
Reserve your seat for our upcoming webinar and hear directly from leading experts about the clinical trials reshaping treatment pathways.
显示更多
Have you secured your place on our free webinar focused on breakthroughs in bladder cancer care?
Register now to be the first to hear key insights from our expert faculty.
Join Prof. Axel Merseburger and Dr. Guru Sonpavde as they discuss the pivotal clinical trials that are reshaping established treatment pathways for bladder cancer.
Bladder cancer management is evolving rapidly and new data are redefining treatment pathways, especially for non-muscle-invasive and muscle-invasive bladder cancer.
Join our experts as they discuss what this means for your clinical practice.
显示更多